JP2021528458A5 - - Google Patents

Info

Publication number
JP2021528458A5
JP2021528458A5 JP2020572804A JP2020572804A JP2021528458A5 JP 2021528458 A5 JP2021528458 A5 JP 2021528458A5 JP 2020572804 A JP2020572804 A JP 2020572804A JP 2020572804 A JP2020572804 A JP 2020572804A JP 2021528458 A5 JP2021528458 A5 JP 2021528458A5
Authority
JP
Japan
Prior art keywords
total weight
pharmaceutical composition
acid
composition according
mannuron
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020572804A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021528458A (ja
Filing date
Publication date
Priority claimed from CN201810711863.8A external-priority patent/CN110652523A/zh
Application filed filed Critical
Publication of JP2021528458A publication Critical patent/JP2021528458A/ja
Publication of JP2021528458A5 publication Critical patent/JP2021528458A5/ja
Pending legal-status Critical Current

Links

JP2020572804A 2018-06-29 2019-06-28 血管性認知症の治療におけるマンヌロン二酸組成物の使用 Pending JP2021528458A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201810711863.8A CN110652523A (zh) 2018-06-29 2018-06-29 甘露糖醛二酸的组合物在治疗血管性痴呆症中的应用
CN201810711863.8 2018-06-29
PCT/CN2019/093813 WO2020001643A1 (zh) 2018-06-29 2019-06-28 甘露糖醛二酸的组合物在治疗血管性痴呆症中的应用

Publications (2)

Publication Number Publication Date
JP2021528458A JP2021528458A (ja) 2021-10-21
JP2021528458A5 true JP2021528458A5 (cg-RX-API-DMAC7.html) 2022-07-05

Family

ID=68985857

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020572804A Pending JP2021528458A (ja) 2018-06-29 2019-06-28 血管性認知症の治療におけるマンヌロン二酸組成物の使用

Country Status (7)

Country Link
US (1) US11406651B2 (cg-RX-API-DMAC7.html)
EP (1) EP3815694A4 (cg-RX-API-DMAC7.html)
JP (1) JP2021528458A (cg-RX-API-DMAC7.html)
KR (1) KR20210040039A (cg-RX-API-DMAC7.html)
CN (1) CN110652523A (cg-RX-API-DMAC7.html)
AU (1) AU2019296854A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020001643A1 (cg-RX-API-DMAC7.html)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1562050A (zh) * 2004-03-24 2005-01-12 中国海洋大学 褐藻酸寡糖在抗痴呆、抗糖尿病中的应用
CN106344593B (zh) * 2015-07-17 2020-01-10 上海绿谷制药有限公司 褐藻胶寡糖及其衍生物在制备治疗血管性痴呆药物中的应用
CN106344592A (zh) 2015-07-17 2017-01-25 上海绿谷制药有限公司 还原端1位为羧基的甘露糖醛酸寡糖及其衍生物在治疗帕金森氏症中的应用
AU2017385332B2 (en) * 2016-12-30 2020-10-29 Green Valley (Shanghai) Pharmaceuticals Co., Ltd. Composition of mannuronic dicarboxylic acid

Similar Documents

Publication Publication Date Title
KR101563379B1 (ko) 아다팔렌 겔의 제조방법
DE60024415T2 (de) Glycin-betain zumr antithrombotischen gebrauch
JP2003505422A5 (cg-RX-API-DMAC7.html)
TW201703759A (zh) 調味劑及含有該調味劑的口腔用組合物
WO2017131130A1 (ja) コンドロイチン硫酸及びヒアルロン酸を含有する安定化された水性組成物
JP2019537589A5 (cg-RX-API-DMAC7.html)
CN101621997B (zh) 医药组合物
JP2021529195A5 (cg-RX-API-DMAC7.html)
JP2021528460A5 (cg-RX-API-DMAC7.html)
JP2021528459A5 (cg-RX-API-DMAC7.html)
JP2001527022A5 (cg-RX-API-DMAC7.html)
EP2814848B1 (en) Partially depolymerized glycosaminoglycan silver and gold salts
JP2010533154A (ja) キトサンカルボキシアルキルアミドのヒドロゲル、その調製およびその美容的および皮膚科的使用
JP2021528458A5 (cg-RX-API-DMAC7.html)
US20100297202A1 (en) Planar antenna and method of manufacturing the same
JP2007517885A5 (cg-RX-API-DMAC7.html)
JP2002145779A5 (cg-RX-API-DMAC7.html)
JP2014521606A (ja) 眼表面アレルギーの処置のための組成物および方法
JP3472442B2 (ja) 損傷皮膚修復用製剤
US20060058261A1 (en) Chitin derivatives for hyperlipidemia
JP7105057B2 (ja) 口腔用組成物
JP2021529196A5 (cg-RX-API-DMAC7.html)
US20150174245A1 (en) Transparent gel
ITMI20071120A1 (it) Composizione antiartrosica
JP6675397B2 (ja) 眼科用組成物